BIOFRONTERA AG

(B8F)
  Rapport
Vertraagde tijd Xetra  -  17:36 24-06-2022
1.195 EUR   -1.65%
09/06Biofrontera AG benoemt Paul Böckmann tot lid van de Raad van Bestuur
CI
17/05Biofrontera AG maakt winstcijfers bekend voor het eerste kwartaal eindigend op 31 maart 2022
CI
13/05Earnings Flash (BFRI) BIOFRONTERA Posts Q1 Revenue $9.8M, vs. Street Est van $9.83M
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op BIOFRONTERA AG
09/06Biofrontera AG Appoints Paul Böckmann to Management Board
08/06PTA-NEWS : Biofrontera AG: Biofrontera's license partner Louis Widmer receives an extensio..
19/05TRANSCRIPT : Biofrontera AG, Q1 2022 Earnings Call, May 19, 2022
17/05NACHBÖRSE/XDAX +0,4% auf 14.237 Pkt - Tui-Aktie unter Druck
17/05Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2022
13/05Earnings Flash (BFRI) BIOFRONTERA Posts Q1 Revenue $9.8M, vs. Street Est of $9.83M
02/05TRANSCRIPT : Biofrontera AG, 2021 Earnings Call, May 02, 2022
30/04Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2021
30/04PTA-NEWS : Biofrontera AG: Biofrontera reports results for the fiscal year 2021
29/04Biofrontera AG Provides Earnings Guidance for the Year 2022
28/04PTA-NEWS : Biofrontera AG: Biofrontera shifts the publication of the Annual Report 2021 to..
14/04PTA-NEWS : Biofrontera AG: Biofrontera announces conference call to be held on April 29, 2..
13/04Top Midday Gainers
13/04Biofrontera Shares Jump 31% After FDA Approves Contract Laboratory for Ameluz
13/04Biofrontera Says FDA Has Approved German Facility as Contract Laboratory for Testing of..
13/04Biofrontera Shares Halted After FDA Approves German Lab for Testing Ameluz
08/04SECTOR UPDATE : Health Care Stocks Enjoy Late Uptick
08/04SECTOR UPDATE : Health Care Stocks Firming in Mostly Higher Market
08/04SECTOR UPDATE : Health Care
08/04European ADRs Move Higher in Friday Trading
08/04Top Premarket Gainers
08/04Earnings Flash (BFRI) BIOFRONTERA Reports Q4 Revenue $9.2M, vs. Street Est of $9.2M
08/04Biofrontera AG Proposes Revenue Guidance for the Year 2022
04/04PTA-NEWS : Biofrontera AG: Governmental price decree for Ameluzģ withdrawn in Spain
04/04PTA-NEWS : Biofrontera AG: Statement of Biofrontera AG on the open letter of Maruho Deutsc..
30/03European ADRs Move Higher in Wednesday Trading
17/03European ADRs Nudge Higher in Thursday Trading
14/03PTA-NEWS : Biofrontera AG: Biofrontera improves the brand protection of Ameluzģ-PDT in the..
14/03Biofrontera AG Improves Brand Protection of Ameluz-PDT
10/03BIOFRONTERA : files Form 15F to suspend SEC Reporting Requirements and starts trading Leve..
09/03PTA-NEWS : Biofrontera AG: Biofrontera files Form 15F to suspend SEC Reporting Requirement..
04/03European ADRs Tumble in Friday Trading
04/03BIOFRONTERA AG(OTCPK : BFAG.Y) dropped from NASDAQ Composite Index
02/03European ADRs Move Sharply Higher in Wednesday Trading
25/02European ADRs Climb Sharply Higher in Friday Trading
24/02BIOFRONTERA AG : Management Board and supervisory board are going to submit proposals for ..
23/02European ADRs Move Higher in Wednesday Trading
22/02European ADRs Move Lower in Tuesday Trading
22/02BIOFRONTERA AG : Changes in the supervisory board - Form 6-K
22/02Biofrontera AG Resigns Franca Ruhwedel as Member of the Supervisory Board
16/02European ADRs Move Higher in Wednesday Trading
15/02European ADRs Move Higher in Tuesday Trading
15/02Biofrontera To Delist ADS From Nasdaq In Cost-Cutting Move
15/02BIOFRONTERA : decides to delist ADS from Nasdaq to reduce complexity and costs - Form 6-K
14/02Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costs
11/02European ADRs Move Higher in Friday Trading
10/02European ADRs Move Higher in Thursday Trading
08/02European ADRs Move Slightly Lower in Tuesday Trading
02/02European ADRs Move Higher in Wednesday Trading
01/02Top Midday Gainers
01/02Biofrontera Completes 70% of Enrollment in Phase 3 of Skin Cancer Study; Shares Rise
01/02BIOFRONTERA : announces progress of phase III study for the treatment of sBCC with Ameluzģ..
01/02PTA-NEWS : Biofrontera AG: Biofrontera AG announces progress of phase III study for the tr..
01/02Biofrontera AG Announces Progress of Phase Iii Study for the Treatment of sBCC with Ame..
28/01European ADRs Move Lower in Friday Trading
25/01European ADRs Move Lower in Tuesday Trading
21/01European ADRs Move Lower in Friday Trading
20/01European ADRs Move Lower in Thursday Trading
13/01BIOFRONTERA : announces preliminary revenue figures for the full year 2021 - Form 6-K
13/01Biofrontera AG Provides Preliminary Revenue Guidance for the Full Year Ending December ..
13/01Biofrontera AG Announces Revenue Results for the Fourth Quarter of 2021
13/01BIOFRONTERA AG : Biofrontera gibt vorläufige Umsatzzahlen für das Gesamtjahr 2021 bekannt
07/01European ADRs Move Higher in Friday Trading
05/01European ADRs Move Higher in Wednesday Trading
03/01European ADRs Move Higher in Monday Trading
2021Biofrontera Says Parent Company Cuts Holdings to Below 50%
2021European ADRs Nudge Higher in Wednesday Trading
2021BIOFRONTERA : announces reduction of shareholding in Biofrontera Inc. below 50% - Form 6-K
2021European ADRs Nudge Lower in Tuesday Trading
2021European ADRs Move Higher in Monday Trading
2021European ADRs Rising Wednesday
2021European ADRs Move Lower in Monday Trading
2021European ADRs Move Lower in Friday Trading
2021Health Care Stocks Continue Gaining into Wednesday Close
2021Health Care Stocks Rising Wednesday Afternoon
1  2  3  4  5  6  7  8  9  10Volgende